Seeking Alpha

Teva Pharmaceutical Industries Ltd. (TEVA)

()
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Latest Transcript
Cramer
Instablogs
  • Nuance, Colgate, and Teva Lead Sentiment Gainers for Week Ending 12/11/09
    Mon December 14, 2009 • Jett Winter • Comment!
  • DR. Reddy's Has been Working
    Sat December 5, 2009 • Glenn Rogers • Comment!
  • Israel’s Reluctant Economic Miracle: Lessons for the US Economy?
    Fri November 27, 2009 • Joseph L. Shaefer • 1 Comment
Write a post on TEVA | More Instablogs on TEVA »
Sentiment
What advice would you give to
TEVA?
123 characters left
Market Currents
  • Thursday 16:46 pm Merck (MRK) says Teva Pharmaceuticals (TEVA) has withdrawn its appeal of a ruling that upheld Merck's patent on allergy medicine Singulair - which brought $4.3B in 2008 sales (18% of the company's revenue), which a generic drug would threaten. Comment!
  • Thursday 10:40 am AstraZeneca (AZN) settles a U.S. patent dispute with Teva Pharmaceuticals (TEVA), protecting its top-selling heartburn drug Nexium from immediate generic competition. Similar to a previous deal with Ranbaxy, the agreement allows Teva to being marketing a generic version in May 2014. Comment!
What's your view of TEVA?
Make sure you include TEVA
140 characters left
More StockTalks on TEVA »